Michael Byas-Smith
Overview
Explore the profile of Michael Byas-Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fine P, Davis M, Muir J, Byas-Smith M
Anesth Analg
. 2018 Jun;
127(1):12-14.
PMID: 29912054
No abstract available.
2.
Byas-Smith M, Prinsell Jr J
Can J Anaesth
. 2012 Dec;
60(3):327-8.
PMID: 23263978
No abstract available.
3.
Wallace M, Charapata S, Fisher R, Byas-Smith M, Staats P, Mayo M, et al.
Neuromodulation
. 2011 Dec;
9(2):75-86.
PMID: 22151630
Objective. The safety and efficacy of intrathecal (IT) ziconotide was studied in a randomized, double-blind, placebo-controlled trial. Materials and Methods. Patients (169 ziconotide, 86 placebo) with severe chronic nonmalignant pain...
4.
Peltier S, Kerssens C, Hamann S, Sebel P, Byas-Smith M, Hu X
Neuroreport
. 2005 Feb;
16(3):285-8.
PMID: 15706237
Low-frequency oscillations (<0.08 Hz) have been detected in functional magnetic resonance imaging studies, and appear to be synchronized between functionally related areas. The effect of anesthetic agents on cortical activity...
5.
Staats P, Yearwood T, Charapata S, Presley R, Wallace M, Byas-Smith M, et al.
JAMA
. 2004 Jan;
291(1):63-70.
PMID: 14709577
Context: Ziconotide (formerly SNX-111) selectively blocks N-type voltage-sensitive calcium channels and may be effective in patients with pain that is refractory to opioid therapy or those with intolerable opioid-related adverse...
6.
Byas-Smith M, Frolich M, Votaw J, Faber T, Hoffman J
Mol Imaging Biol
. 2003 Oct;
4(2):139-46.
PMID: 14537136
Purpose: This work determined if 2, 6-diisopropylphenol (propofol) selectively affects cerebral blood flow in regions associated with wakefulness. Procedures: Cerebral blood flow (CBF) was measured with positron emission tomography (PET)...
7.
Byas-Smith M, Votaw J, Hua J, Voll R, Martarello L, Levey A, et al.
Mol Imaging Biol
. 2003 Sep;
5(4):217-26.
PMID: 14499136
Purpose: 8-(2-[18F]fluoroethyl)-2 beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane ([18F]FECNT) is a radiotracer for positron emission tomography (PET) used to trace the location and binding potential (BP) of the dopamine transporter (DAT). We tested the hypothesis...
8.
Votaw J, Byas-Smith M, Hua J, Voll R, Martarello L, Levey A, et al.
Anesthesiology
. 2003 Jan;
98(2):404-11.
PMID: 12552200
Background: Isoflurane administration is known to increase extracellular dopamine (DA) concentration. Because the dopamine transporter (DAT) is a key regulator of DA, it is likely affected by isoflurane. This study...